Podcast: Psychological Effects of COVID-19
Evaluation and Credit: https://www.surveymonkey.com/r/MedChat25Part1
This activity is targeted toward primary care specialties.
Statement of Need
It is estimated that approximately 7-8% of the population suffers from PTSD at some point in their lives. Research shows that patients with PTSD symptoms are often undiagnosed in primary care, which is typically where these patients see health care providers for either co-morbidities or complaints that are manifested as a result of PTSD (anxiety, trouble sleeping, etc.). Research indicates that PCPs may lack the knowledge of common risk factors that indicate screening for PTSD; therefore this condition often goes undiagnosed and managed. (Harvard Review of Psychiatry, Journal of Psychosocial Nursing, etc.)Objectives
At the conclusion of this offering, the participant will be able to:
SpeakerMark Schirmer, Psy.D., HSP Psychologist Norton Behavioral Health
Moderator, Speaker and Planner Disclosures
The speaker, moderator and planners for this activity have no potential or actual conflicts of interest to disclose.
There was no commercial support for this activity.
American Medical Association
Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.
Norton Healthcare designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of Original Release |April 2021Course Termination Date | April 2023
Contact Information | Center for Continuing Medical Education; (502) 446-5955 or firstname.lastname@example.org
Resources for Additional Study
Prevalence and risk factors for acute posttraumatic stress disorder during the COVID-19 outbreak
Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: Clinical implications for U.S. young adult mental health
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors